JAVELIN renal 101: A phase 3 study of avelumab in combination with axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma (aRCC) Meeting Abstract
| Authors: | Choueiri, T. K.; Rini, B. I.; Cosgriff, T.; Miyake, H.; Vogelzang, N. J.; Kannourakis, G.; Mariani, M.; Chiruzzi, C.; Albiges, L.; Haanen, J. B.; Larkin, J.; Atkins, M. B.; Schmidinger, M.; Magazzù, D.; Di Pietro, A.; Motzer, R. J. |
| Abstract Title: | JAVELIN renal 101: A phase 3 study of avelumab in combination with axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma (aRCC) |
| Meeting Title: | 15th International Kidney Cancer Symposium |
| Journal Title: | BJU International |
| Volume: | 118 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2016 Nov 4-5 |
| Meeting Location: | Miami, FL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2016-12-01 |
| Start Page: | 29 |
| End Page: | 30 |
| Language: | English |
| ACCESSION: | WOS:000388478200049 |
| PROVIDER: | wos |
| PUBMED: | 27860174 |
| DOI: | 10.1111/bju.13694 |
| Notes: | Meeting Abstract -- Source: Wos |
